Clinical trial Recruiting at 1 site Observational Ages 18 and up

Long-term follow-up on cancer treatment effects and patient quality of life

Official title: Non-interventional and Longitudinal Study to Evaluate a List of Anticancer Drugs Under Real Conditions of Use and Measure the Quality of Life of Patients Treated at Rafaël Institute

Run by Institut Rafael · NCT06317714 · Data updated 2026-11-12

This study is trying to see how new cancer treatments affect patients' lives and well-being over time.

More Quality of Life (QOL) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorInstitut Rafael
Academic / other
Locations1 site (Levallois-Perret, Institut Rafael)
StatusRecruiting
StartedMarch 8, 2024
Main results expectedMarch 8, 2027
Study endsMarch 8, 2027
Registry record updatedOctober 1, 2024
Trial IDNCT06317714 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are receiving innovative or expensive anticancer therapies at the Rafael Institute.

Probably not a fit

Patients under 18 years old or those unable to provide consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a registry that collects data on the safety and effectiveness of innovative anticancer drugs in real-life settings while also measuring the quality of life of patients undergoing these treatments. The Rafael Institute focuses on a patient-centered approach, emphasizing the importance of personalized care and continuous support from a multidisciplinary team. By documenting the relationship between treatment side effects and quality of life, the study seeks to enhance the overall management of cancer patients and address their needs more effectively.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of the quality of life for cancer patients undergoing treatment.

How similar studies have gone: Other studies focusing on quality of life in cancer patients have shown success, indicating that this approach is valuable and relevant.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age equal to or greater than 18 years (adult)
* Patients treated with an anticancer drug included in the list of innovative/expensive therapies (protocol appendix)
* Patients benefiting from non-pharmacological treatment at the Rafael Institute
* Who understands the French language

Exclusion Criteria:

* \< 18 years old
* Patient deprived of liberty, under guardianship or unable to give consent

Where it's running

  • Institute Rafaël
    Levallois-Perret, Institut Rafael, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.